Code of Good Practice in the Pharmaceutical Industry
Code of Good Practice in the Pharmaceutical Industry
On
19 April 2016, the Association of European Businesses (AEB) and the Federal Antimonopoly Service (FAS) held a joint press conference to present the Code of Good Practice in the Pharmaceutical Industry.
The Code is a set of rules governing the acceptable behaviour of participants in the pharmaceutical market. It applies to participants of the medicines market. The Code includes provisions on contractual relationships between manufacturers of drugs and buyers, the liaison procedure with distributors, commercial terms and conditions for supplying to state sector customers, settlement of disputes between the parties to the Code, and much more.
The list of
Companies that joined the Code of Good Practice can be downloaded in pdf HERE (latest update — 15 November 2018)
.